Skip to main content
SpringerLink
Log in

Monophosphoryl Lipid A as an Adjuvant

Past Experiences and New Directions

  • Chapter
Vaccine Design

Part of the book series: Pharmaceutical Biotechnology ((PBIO,volume 6))

Abstract

The increasing threat to the human population posed by new or resurgent infectious diseases, coupled with an alarming rise in the incidence of antibiotic-resistant microbes, has created a tremendous need for new vaccines. A critical element in the development of these new vaccines is the ability, via adjuvants, to potentiate and focus the immune response to the vaccine in beneficial ways so that optimal protection can be achieved. One promising candidate adjuvant in this regard is MPL® immunostimulant, a monophosphoryl lipid A preparation derived from the lipopolysaccharide (LPS) of Salmonella minnesota R595. MPL® is being considered as an adjuvant for a number of human vaccines, and experience to date has shown that it is safe, well tolerated, and able to provide a heightened immune response to coadministered antigens. In this chapter, various topics related to the preparation, formulation, and use of MPL® as an adjuvant will be discussed. In addition, our current knowledge of the mechanisms of action of MPL® will be reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Altman, A., and Dixon, F. J., 1989, Immunomodifiers in vaccines, Adv. Vet. Sci. Comp. Med. 33:301–343.

    PubMed  CAS  Google Scholar 

  • Alving, C. R., 1991, Liposomes as carriers of antigens and adjuvants, J. Immunol. Methods 140:1–13.

    Article  PubMed  CAS  Google Scholar 

  • Alving, C. R., 1992, Lipid A and liposomes containing lipid A as adjuvants for vaccines, in: Bacterial Endotoxic Lipopolysaccharides, Vol. 2 (J. L. Ryan and D. C. Morrison, eds.), CRC Press, Boca Raton, pp. 430–443.

    Google Scholar 

  • Baker, P. J., 1990, Regulation of magnitude of antibody response to bacterial Polysaccharide antigens by thymus-derived lymphocytes, Infect. Immun. 58:3465–3468.

    PubMed  CAS  Google Scholar 

  • Baker, P. J., and Prescott, B., 1979, Regulation of the antibody response to pneumococcal Polysaccharides by thymus-derived (T) cells: Mode of action of suppressor and amplifier T cells, in: Immunology of Bacterial Polysaccharides (J. A. Rudbach and P. J. Baker, eds.), Elsevier/North-Holland, Amsterdam, pp. 67–105.

    Google Scholar 

  • Baker, P. J., Hiernaux, J. R., Fauntleroy, M. B., Stashak, P. W., Prescott, B., Cantrell, J. L., and Rudbach, J. A., 1988a, Inactivation of suppressor T-cell activity by nontoxic monophosphoryl lipid A, Infect. Immun. 56:1076–1083.

    PubMed  CAS  Google Scholar 

  • Baker, P. J., Hiernaux, J. R., Fauntleroy, M. B., Prescott, B., Cantrell, J. L., and Rudbach, J. A., 1988b, Ability of monophosphoryl lipid A to augment the antibody response of young mice, Infect. Immun. 56:3064–3066.

    PubMed  CAS  Google Scholar 

  • Baker, P. J., Haslov, K. R., Fauntleroy, M. B., Stashak, P. W., Myers, K., and Ulrich, J. T., 1990, Enrichment of suppressor T cells by means of binding to monophosphoryl lipid A, Infect. Immun. 58:726–731.

    PubMed  CAS  Google Scholar 

  • Batley, M., Packer, N. H., and Redmond, J. W., 1985, Analytical studies of lipopolysaccharide and its derivatives from Salmonella minnesota R595. I. Phosphorous magnetic resonance spectra, Biochim. Biophys. Acta 821:179–194.

    Article  CAS  Google Scholar 

  • Bessler, W. G., and Jung, G., 1992, Synthetic lipopeptides as novel adjuvants, Res. Immunol. 5:548–553.

    Article  Google Scholar 

  • Brachman, P. S., Gold, H., Plotkin, S. A., Fekety, F. R., Werrin, M., and Ingraham, N. R., 1962, Field evaluation of a human anthrax vaccine, Am. J. Public Health 52:632–645.

    Article  CAS  Google Scholar 

  • Brozek, K. A., and Raetz, C. R. H., 1990, Biosynthesis of lipid A in Escherichia coli. Acyl carrier protein-dependent incorporation of laurate and myristate, J. Biol. Chem. 265:15410–15417.

    PubMed  CAS  Google Scholar 

  • Caroff, M., Deprun, C., Karibian, D., and Szabó, L., 1991, Analysis of unmodified endotoxin preparations by Cf plasma desorption mass spectrometry. Determination of molecular masses of the constituent native lipopolysaccharides, J. Biol. Chem. 266:18543–18549.

    PubMed  CAS  Google Scholar 

  • Carozzi, S., Salit, M., Cantaluppi, A., Nasini, M. G., Barocci, S., Cantarella, S., and Lamperi, S., 1989, Effect of monophosphoryl lipid A on the in vitro function of peritoneal leukocytes from uremic patients on continuous ambulatory peritoneal dialysis, J. Clin. Microbiol. 27:1748–1753.

    PubMed  CAS  Google Scholar 

  • Chase, J. J., Kubey, W., Dulek, M. H., Holmes, C. J., Salit, M. G., Pearson, F. C., III, and Ribi, E., 1986, Effect of monophosphoryl lipid A on host resistance to bacterial infection, Infect. Immun. 53:711–712.

    PubMed  CAS  Google Scholar 

  • Chen, C. H., Johnson, A. G., Kasai, N., Key, B. A., Levin, J., and Nowotny, A., 1973, Heterogeneity and biological activity of endotoxic glycolipid from Salmonella minnesota R595, J. Infect. Dis. 128(Suppl):43–51.

    Article  PubMed  Google Scholar 

  • Codington, J. F., Linsley, K. B., and Jeanlot, R. W., 1975, Immunochemical and chemical investigations of the structure of glycoprotein fragments obtained from epiglycanin, a glycoprotein at the surface of the TA3-Ha cancer cell, Carbohydr. Res. 40:171–182.

    Article  PubMed  CAS  Google Scholar 

  • Collins, D. S., Findlay, K., and Harding, C. V., 1992, Processing of exogenous liposome-encapsulated antigen in vivo generates class I MHC-restricted T cell responses, J. Immunol. 148:3336–3341.

    PubMed  CAS  Google Scholar 

  • Deres, K., Schild, H., Wiesmuller, K.-H., Jung, G., and Rammensee, H. G., 1989, In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine, Nature 342:561–564.

    Article  PubMed  CAS  Google Scholar 

  • Devi, S. J. N., Schneerson, R., Egan, W., Ulrich, J. T., Bryla, D., Robbins, J. B., and Bennett, J. E., 1991, Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: Synthesis, characterization, and immunogenicity, Infect. Immun. 59:3700–3707.

    PubMed  CAS  Google Scholar 

  • DeWilde, M., 1994, Preclinical and clinical experience with MPL and QS21 adjuvanted recombinant subunit vaccines, in: Novel Vaccine Strategies, IBC Conference, February, Bethesda, Maryland.

    Google Scholar 

  • Dijkstra, J., Mellors, J. W., Ryan, J. L., and Szoka, F. C., 1987, Modulation of the biological activity of bacterial endotoxin by incorporation into liposomes, J. Immunol. 138:2663–2670.

    PubMed  CAS  Google Scholar 

  • Domer, J. E., Garner, R. E., and Befidi-Mengue, R. N., 1989, Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI, Infect. Immun. 57:693–700.

    PubMed  CAS  Google Scholar 

  • Domer, J. E., Human, L. G., Andersen, G. B., Rudbach, J. A., and Asherson, G. L., 1993, Abrogation of suppression of delayed hypersensitivity induced by Candida albicans-derived mannan by treatment with monophosphoryl lipid A, Infect. Immun. 61:2122–2130.

    PubMed  CAS  Google Scholar 

  • Edelman, R., 1992, An update on vaccine adjuvants in clinical trial, AIDS Res. Hum. Retroviruses 8:1409–1411.

    PubMed  CAS  Google Scholar 

  • Elliott, G. T., McLeod, R. A., Perez, J., and Von Eschen, K. B., 1993, Interim results of a Phase II multicenter clinical trial evaluating the activity of a therapeutic allogeneic melanoma vaccine (Theraccine) in the treatment of disseminated malignant melanoma, Semin. Surg. Oncol. 9:264–272.

    PubMed  CAS  Google Scholar 

  • Engelhardt, R., Mackensen, A., Galanos, C., and Andreesen, R., 1990, Biological response to intravenously administered endotoxin in patients with advanced cancer, J. Biol. Response Mod. 9:480–491.

    PubMed  CAS  Google Scholar 

  • Esquivel, F., Taylor, C. E., and Baker, P. J., 1991, Differential sensitivity of CD8+ suppressor and cytotoxic T lymphocyte activity to bacterial monophosphoryl lipid A, Infect. Immun. 59:2994–2998.

    PubMed  CAS  Google Scholar 

  • Finkelman, F. D., Holmes, J., Katona, I. M., Urban, J. F., Jr., Beckmann, M. P., Park, L. S., Schooley, K. A., Coffman, R. L., Mosmann, T. R., and Paul, W. E., 1990, Lymphokine control of in vivo immunoglobulin isotype selection, Annu. Rev. Immunol. 8:303–333.

    Article  PubMed  CAS  Google Scholar 

  • Florence, A. T., and Whitehill, D., 1982, The formulation and stability of multiple emulsions, Int. J. Pharm. 11:277–308.

    Article  CAS  Google Scholar 

  • Friede, M., Muller, S., Briand, J.-P., Van Regenmortel, M. H. V., and Schuber, F., 1993, Induction of immune response against a short synthetic peptide antigen coupled to small neutral liposomes containing monophosphoryl lipid A, Mol. Immunol. 30:539–547.

    Article  PubMed  CAS  Google Scholar 

  • Fries, L. F., Gordon, D. M., Richards, R. L., Egan, J. E., Hollingdale, M. R., Gross, M., Silverman, C., and Alving, C. R., 1992, Liposomal malaria vaccine in humans: A safe and potent adjuvant strategy, Proc. Natl. Acad. Sci. USA 89:358–362.

    Article  PubMed  CAS  Google Scholar 

  • Fung, P. Y. S., and Longenecker, B. M., 1991, Specific immunosuppressive activity of epiglycanin, a mucin-like glycoprotein secreted by a murine mammary adenocarcinoma (TA3-HA), Cancer Res. 51:1170–1176.

    PubMed  CAS  Google Scholar 

  • Fung, P. Y. S., Madej, M., Koganty, R. R., and Longenecker, B. M., 1990, Active specific immunotherapy of a murine mammary adenocarcinoma using a synthetic tumor-associated glycoconjugate, Cancer Res. 50:4308–4314.

    PubMed  CAS  Google Scholar 

  • Garcon, N. M. J., and Six, H. R., 1991, Universal vaccine carrier. Liposomes that provide T-dependent help to weak antigens, J. Immunol. 146:3697–3702.

    PubMed  CAS  Google Scholar 

  • Garg, M., and Subbarao, B., 1992, Immune responses of systemic and mucosal lymphoid organs to Pnu-Imune vaccine as a function of age and the efficacy of monophosphoryl lipid A as an adjuvant, Infect. Immun. 60:2329–2336.

    PubMed  CAS  Google Scholar 

  • Good, M. F., Maloy, W. L., Lunde, M. N., Margalit, H., Corvette, J. L., Smith, G. L., Moss, B., Miller, L. H., and Berzofsky, J. A., 1987, Construction of synthetic immunogen: Use of new T-helper epitope on malaria circumsporozoite protein, Science 235:1059–1062.

    Article  PubMed  CAS  Google Scholar 

  • Gregoriadis, G., 1990, Immunological adjuvants: A role for liposomes, Immunol. Today 11:89–97.

    Article  PubMed  CAS  Google Scholar 

  • Griffioen, A. W., Rijkers, G. T., Toebes, E. A. H., and Zegers, B. J. M., 1991, The human in vitro anti-type 4 pneumococcal polysaccharide antibody response is regulated by suppressor T cells, Scand. J. Immunol. 34:229–236.

    Article  PubMed  CAS  Google Scholar 

  • Griffioen, A. W., Toebes, E. A., Rijkers, G. T., Claas, F. H., Datema, G., and Zegers, B. J. M., 1992, The amplifier role of T cells in the human in vitro B cell response to type 4 pneumococcal polysaccharide, Immunol. Lett. 32:265–272.

    Article  PubMed  CAS  Google Scholar 

  • Gustafson, G. L., and Rhodes, M. J., 1992a, A rationale for the prophylactic use of monophosphoryl lipid A in sepsis and septic shock, Biochem. Biophys. Res. Commun. 182:269–275.

    Article  PubMed  CAS  Google Scholar 

  • Gustafson, G. L., and Rhodes, M. J., 1992b, Bacterial cell wall products as adjuvants: Early interferon gamma as a marker for adjuvants that enhance protective immunity, Res. Immunol. 143:483–488.

    Article  PubMed  CAS  Google Scholar 

  • Gustafson, G. L., and Rhodes, M. J., 1994, Effects of tumor necrosis factor and dexamethasone on the regulation of interferon-γ induction by monophosphoryl lipid A, J. Immunother. 15:129–133.

    Article  CAS  Google Scholar 

  • Hadjipetrou-Kourounakis, L., and Moller, E., 1984, Adjuvants influence the immunoglobin subclass distribution of immune responses in vivo, Scand. J. Immunol. 19:219–225.

    Article  PubMed  CAS  Google Scholar 

  • Havell, E. A., 1989, Evidence that tumor necrosis factor has an important role in antibacterial resistance, J. Immunol. 143:2894–2899.

    PubMed  CAS  Google Scholar 

  • Hocart, M. J., MacKenzie, J. S., and Stewart, G. A., 1989, The immunoglobulin G subclass responses of mice to influenza A virus: The effect of mouse strain, and the neutralizing abilities of individual protein A-purified subclass antibodies, J. Gen. Virol. 70:2439–2448.

    Article  PubMed  CAS  Google Scholar 

  • Hunsmann, G., Schneider, J., and Schulz, A., 1981, Immunoprevention of Friend virus-induced erythroleukemia by vaccination with viral envelope glycoprotein complexes, Virology 113:602–612.

    Article  PubMed  CAS  Google Scholar 

  • Ishihara, C., Miyazawa, M., Nishio, J., Azuma, I., and Chesebro, B., 1992, Use of low toxicity adjuvants and killed virus to induce protective immunity against the Friend murine leukaemia retrovirus-induced disease, Vaccine 10:353–356.

    Article  PubMed  CAS  Google Scholar 

  • Ivins, B. E., Ezzell, J. W., Jr., Jemski, J., Hedlund, K. W., Ristroph, J. D., and Leppla, S. H., 1986, Immunization studies with attenuated strains of Bacillus anthracis, Infect. Immun. 52:454–458.

    PubMed  CAS  Google Scholar 

  • Ivins, B. E., Welkos, S. L., Little, S. F., Crumine, M. H., and Nelson, G. O., 1992, Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants, Infect. Immun. 60:662–668.

    PubMed  CAS  Google Scholar 

  • Ivins, B. E., Fellows, P. E, Welkos, S. L., and Pitt, M. L., 1993, Experimental anthrax vaccines: Efficacy studies in guinea pigs, Abstr. E-104, Am. Soc. Microbiol. Annu. Meet., May, p. 160.

    Google Scholar 

  • Izui, S., Eisenberg, R. A., and Dixon, F. J., 1981, Subclass-restricted IgG polyclonal antibody production in mice injected with lipid A-rich lipopolysaccharides, J. Exp. Med. 153:324–338.

    Article  PubMed  CAS  Google Scholar 

  • Johnson, A. G., 1964, Adjuvant action of bacterial endotoxins on the primary antibody response, in: Bacterial Endotoxins (M. Landy and W. Braun, eds.), Rutgers University Press, New Brunswick, pp. 252–262.

    Google Scholar 

  • Johnson, A. G., Gains, S., and Landy, M., 1956, Studies on the O antigen of Salmonella typhosa. V. Enhancement of antibody responses to protein antigens by the purified lipopolysaccharide, J. Exp. Med. 103:225–246.

    Article  PubMed  CAS  Google Scholar 

  • Kaufmann, S. H. E., Vath, U., Thole, J. E. R., Van Embden, J. D. A., and Emmrich, F., 1987, Enumeration of T cells reactive with Mycobacterium tuberculosis organisms and specific for the recombinant mycobacterial 64-KDa protein, Eur. J. Immunol. 17:351–357.

    Article  PubMed  CAS  Google Scholar 

  • Keane, W. F., and Peterson, P. K., 1984, Host defense mechanisms of peritoneal cavity and continuous ambulatory peritoneal dialysis, Peritoneal Dial. Bull. 4:122–127.

    Google Scholar 

  • Kenney, J. S., Hughes, B. W., Masada, M. P., and Allison, A. C., 1989, Influence of adjuvants on the quantity, affinity, isotype, and epitope specificity of murine antibodies, J. Immunol. Methods 121:157–166.

    Article  PubMed  CAS  Google Scholar 

  • Klein, J. O., 1981, The epidemiology of pneumococcal disease in infants and children, Rev. Infect. Dis. 3:246–253.

    Article  PubMed  CAS  Google Scholar 

  • Kotani, S., and Takada, H., 1989, Structural requirements of lipid A for endotoxicity and other biological activities — An overview, Crit. Rev. Microbiol. 16:477–523.

    Article  PubMed  Google Scholar 

  • Lamperi, S., Carozzi, S., Icardi, A., and Nasini, M. G., 1985, Peritoneal membrane defense mechanism in CAPD, Trans. Am. Soc. Artif. Intern. Organs 31:33–37.

    PubMed  CAS  Google Scholar 

  • Leroux-Roels, G., Moreux, E., Verhasselt, B., Biernaux, S., Brulein, V., Francotte, M., Pala, P., Slaoui, M., and Vandepapeliere, P., 1993, Immunogenicity and reactogenicity of a recombinant HSV-2 glycoprotein D vaccine with or without monophosphoryl lipid A in HSV seronegative and seropositive subjects, Abstr. 1209, 33rd Intersci. Conf. Antimicrob. Agents Chemother., p. 341.

    Google Scholar 

  • MacLean, G. D., Bowen-Yacyshyn, M. B., Samuel, J., Meikle, A., Stuart, G., Nation, J., Poppema, S., Jerry, M., Koganty, R., Wong, T., and Longenecker, B. M., 1992, Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen, J. Immunother. 11:292–305.

    Article  PubMed  CAS  Google Scholar 

  • MacLean, G. D., Reddish, M., Koganty, R. R., Wong, T., Gandhi, S., Smolenski, M., Samuel, J., Nabholtz, J. M., and Longenecker, B. M., 1993, Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant, Cancer Immunol. Immunother. 36:215–222.

    Article  PubMed  CAS  Google Scholar 

  • Marr, A. G., and Ingraham, J. L., 1962, Effect of temperature on the composition of fatty acids in Escherichia coli, J. Bacteriol. 84:1260–1267.

    PubMed  CAS  Google Scholar 

  • Martich, G. D., Danner, R. L., Ceska, M., and Suffredini, A. F, 1991, Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: The effect of antiinflammatory agents, J. Exp. Med. 173:1021–1024.

    Article  PubMed  CAS  Google Scholar 

  • Masihi, K. N., Lange, W., Johnson, A. G., and Ribi, E., 1986, Enhancement of chemiluminescence and phagocytic activities by nontoxic and toxic forms of lipid A, J. Biol. Response Mod. 5:462–469.

    PubMed  CAS  Google Scholar 

  • Michie, H. R., Manogue, K. R., Spriggs, D. R., Revhaug, A., O’Dwyer, S., Dinarello, C. A., Cerami, A., Wolff, S. M., and Wilmore, D. W., 1988, Detection of circulating tumor necrosis factor after endotoxin administration, N. Engl. J. Med. 318:1481–1486.

    Article  PubMed  CAS  Google Scholar 

  • Mitchell, M. S., Kan-Mitchell, J., Kempf, R. A., Hard, W., Shau, H. Y., and Lind, S., 1988, Active specific immunotherapy for melanoma: Phase I trial of allogeneic lysates and a novel adjuvant, Cancer Res. 48:5883–5893.

    PubMed  CAS  Google Scholar 

  • Mitchell, M. S., Harel, W., Kempf, R. A., Hu, E., Kan-Mitchell, J., Boswell, W. D., Dean, G., and Stevenson, L., 1990, Active-specific immunotherapy for melanoma, J. Clin. Oncol. 8:856–869.

    PubMed  CAS  Google Scholar 

  • Mosier, D. E., and Subbarao, B., 1982, Thymus-independent antigens: Complexity of B lymphocyte activation revealed, Immunol. Today 3:217–222.

    Article  Google Scholar 

  • Mosier, D. E., Zaldivar, N. M., Goldings, E., Mond, J., Scher, I., and Paul, W. E., 1977, Formation of antibody in the newborn mouse: Study of T-cell-independent antibody response, J. Infect. Dis. 136 (Suppl.):S14–S19.

    Article  PubMed  Google Scholar 

  • Munoz, J., 1964, Effects of bacteria and bacterial products on antibody response, in: Advances in Immunology (F. J. Dixon and H. G. Kunkel, eds.), Academic Press, New York, pp. 397–440.

    Google Scholar 

  • Myers, K. R., and Snyder, D. S., 1992, Detailed composition of natural MPL®-immunostimulant, J. Cell. Biochem., Abstr. Suppl. 16C, abstract CB112.

    Google Scholar 

  • Myers, K. R., and Ulrich, J. T., 1993, Effective use of monophosphoryl lipid A as an adjuvant, in: Novel Vaccine Strategies, IBC Conference, October, Bethesda.

    Google Scholar 

  • Myers, K. R., Truchot, A. T., Ward, J., Hudson, Y., and Ulrich, J. T., 1990, A critical determinant of lipid A endotoxic activity, in: Cellular and Molecular Aspects of Endotoxin Reactions (A. Nowotny, J. J. Spitzer, and E. J. Ziegler, eds.), Elsevier, Amsterdam, pp. 145–156.

    Google Scholar 

  • Myers, K. R., Ulrich, J. T., Qureshi, N., Takayama, K., Wang, R., Chen, L., Emary, W. B., and Cotter, R. J., 1992, Preparation and characterization of biologically active 6′-O-(6-aminocaproyl)-4′-O-monophosphoryl lipid A and its conjugated derivative, Bioconjugate Chem. 3:540–548.

    Article  CAS  Google Scholar 

  • Olander, R.-M., Muotiala, A., Himanen, J.-P., Karvonen, M., Airaksinen, U., and Runeberg-Nyman, K., 1991, Immunogenicity and protective efficacy of pertussis toxin subunit S1 produced by Bacillus subtilis, Microb. Pathog. 10:159–164.

    Article  PubMed  CAS  Google Scholar 

  • Peltola, H., Kayhty, H., Virtanen, M., and Makela, P. H., 1984, Prevention of Haemophilus influenzae type B bacteremic infections with the capsular Polysaccharide vaccine, N. Engl. J. Med. 310:1561–1566.

    Article  PubMed  CAS  Google Scholar 

  • Pohle, C., Rohde-Schultz, B., and Masihi, K. N., 1990, Effects of synthetic HIV peptides, cytokines, and monophosphoryl lipid A on chemiluminescence response, in: Immunotherapeutic Disease (K. N. Masihi and W. Lange, eds.), Springer-Verlag, Berlin, pp. 143–149.

    Chapter  Google Scholar 

  • Puziss, M., Manning, L. C., Lynch, L. W., Barclay, E., Abelow, I., and Wright, G. G., 1963, Large-scale production of protective antigen of Bacillus anthracis anaerobic cultures, Appl. Microbiol. 11:330–334.

    PubMed  CAS  Google Scholar 

  • Qureshi, N., Takayama, K., and Ribi, E., 1982, Purification and structural determination of nontoxic lipid A obtained from lipopolysaccharide of Salmonella typhimurium, J. Biol. Chem. 257:11808–11815.

    PubMed  CAS  Google Scholar 

  • Qureshi, N., Mascagni, P., Ribi, E., and Takayama, K., 1985, Monophosphoryl lipid A obtained from lipopolysaccharides of Salmonella minnesota R595: Purification of the dimethyl derivative by high performance liquid chromatography and complete structural determination, J. Biol. Chem. 260:5271–5278.

    PubMed  CAS  Google Scholar 

  • Qureshi, N., Cotter, R. J., and Takayama, K., 1986, Application of fast atom bombardment mass spectrometry and nuclear magnetic resonance on the structural analysis of purified lipid A, J. Microbiol. Methods 5:65–77.

    Article  CAS  Google Scholar 

  • Rawlings, D. J., and Kaslow, D. C., 1992, Adjuvant-dependent immune response to malarial transmissionblocking vaccine candidate antigens, J. Exp. Med. 176:1483–1487.

    Article  PubMed  CAS  Google Scholar 

  • Ribi, E., 1984, Beneficial modification of the endotoxin molecule, J. Biol. Response Mod. 3:1–9.

    PubMed  CAS  Google Scholar 

  • Ribi, E., 1986, Structure-function relationship of bacterial adjuvants, in: Advances in Carriers and Adjuvants for Veterinary Biologics (R. M. Nervig, P. M. Gough, M. L. Kaeberle, and C. A. Whetstone, eds.), Iowa State University Press, Ames, pp. 35–49.

    Google Scholar 

  • Ribi, E., Parker, R., Strain, S. M., Mizuno, Y., Nowotny, A., Von Eschen, K. B., Cantrell, J. L., McLaughlin, C. A., Hwang, K. M., and Goren, M. B., 1979, Peptides as requirement for immunotherapy of the guinea-pig Line 10 tumor with endotoxins, Cancer Immunol. Immunother. 7:43–58.

    Article  Google Scholar 

  • Ribi, E., Amano, K., Cantrell, J., Schwartzman, S., Parker, R., and Takayama, K., 1982, Preparation and antitumor activity of nontoxic lipid A, Cancer Immunol. Immunother. 12:91–96.

    Article  CAS  Google Scholar 

  • Ribi, E., Cantrell, J. L., Takayama, K., Ribi, H. O., Myers, K. R., and Qureshi, N., 1986, Modulation of humoral and cell-mediated immune responses by a structurally established nontoxic lipid A, in: Immunobiology and Immunopharmacology of Bacterial Endotoxins (A. Szentivanyi and H. Friedman, eds.), Plenum Press, New York, pp. 407–420.

    Chapter  Google Scholar 

  • Rickman, L. S., Gordon, D. M., Wistar, R. Jr., Krzych, U., Gross, M., Hollingdale, M. R., Egan, J. E., Chulay, J. D., and Hoffman, S. L., 1991, Use of adjuvant containing mycobacterial cell-wall skeleton, monophosphoryl lipid A, and squalane in malaria circumsporozoite protein vaccine, Lancet 337:998–1001.

    Article  PubMed  CAS  Google Scholar 

  • Rietschel, E. T., Wollenweber, H.-W., Russa, R., Brade, H., and Zähringer, U., 1984, Concepts of the chemical structure of lipid A, Rev. Infect. Dis. 6:432–438.

    Article  PubMed  CAS  Google Scholar 

  • Robbins, J. B., and Schneerson, R., 1990, Polysaccharides-protein conjugates: A new generation of vaccines, J. Infect. Dis. 161:821–832.

    Article  PubMed  CAS  Google Scholar 

  • Roghmann, K. J., Tabloski, P. A., Bentley, D. W., and Schiffman, G., 1987, Immune response of elderly adults to pneumococcus: Variation by age, sex, and functional impairment, J. Gerontol. 42:265–270.

    Article  PubMed  CAS  Google Scholar 

  • Romagnani, S., 1992, Induction of TH1 and TH2 responses: A key role for the “natural” immune response? Immunol. Today 13:379–381.

    Article  PubMed  CAS  Google Scholar 

  • Rook, G. A., 1991, Mobilizing the appropriate T-cell subset: The immune response as taxonomist? Tubercle 72:253–254.

    Article  PubMed  CAS  Google Scholar 

  • Rook, G. A. W., 1993, New meanings for an old word: Adjuvanticity, cytokines and T cells, Immunol. Today 14:95–96.

    Article  PubMed  CAS  Google Scholar 

  • Rudbach, J. A., Cantrell, J. L., and Ulrich, J. T., 1988, Molecularly engineered microbial immunostimulators, in: Technological Advances in Vaccine Development (L. Lasky, ed.), Liss, New York, pp. 443–454.

    Google Scholar 

  • Rudbach, J. A., Cantrell, J. L., Ulrich, J. T., and Mitchell, M. S., 1990, Immunotherapy with bacterial endotoxins, in: Endotoxin (H. Friedman, T. W. Klein, M. Nakano, and A. Nowotny, eds.), Plenum Press, New York, pp. 665–676.

    Google Scholar 

  • Rudbach, J. A., Myers, K. R., Rechtman, D. J., and Ulrich, J. T., 1994, Prophylactic use of monophosphoryl lipid A in patients at risk for sepsis, in: Bacterial Endotoxins: Basic Science to Anti-Sepsis Strategies (J. Levin, S. J. H. Van Deventer, A. Sturk, and T. Van Der Poll, eds.), Wiley, New York, pp. 107–124.

    Google Scholar 

  • Schneerson, R., Fattom, A., Szu, S. C., Bryla, D., Ulrich, J. T., Rudbach, J. A., Schiffman, G., and Robbins, J. B., 1991, Evaluation of monophosphoryl lipid A (MPL) as an adjuvant. Enhancement of serum antibody response in mice to polysaccharide-protein conjugates by concurrent injection with MPL, J. Immunol. 147:2136–2140.

    PubMed  CAS  Google Scholar 

  • Shapiro, E. D., Wald, E. R., Margolis, A. G., and Ortenzo, M. E., 1992, The decreasing incidence of Hemophilus influenza type B (Hib) disease in both Connecticut and Greater Pittsburgh, PA., Pediatr. Res. 31:100A.

    Google Scholar 

  • Springer, G. F., 1984, T and Tn, general carcinoma autoantigens, Science 224:1198–1206.

    Article  PubMed  CAS  Google Scholar 

  • Takahashi, H., Takeshita, T., Morein, B., Putney, S., Germain, R. N., and Berzofsky, J. A., 1990, Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope proteins in ISCOMs, Nature 344:873–875.

    Article  PubMed  CAS  Google Scholar 

  • Takayama, K., Ribi, E., and Cantrell, J. L., 1981, Isolation of a nontoxic lipid A fraction containing tumor regression activity, Cancer Res. 41:2654–2657.

    PubMed  CAS  Google Scholar 

  • Takayama, K., Qureshi, N., Raetz, C. R. H., Ribi, E., Peterson, J., Cantrell, J. L., Pearson, F. C., Wiggins, J., and Johnson, A. G., 1984, Influence of fine structure of lipid Aon Limulus amebocyte lysate clotting and toxic activities, Infect. Immun. 45:350–355.

    PubMed  CAS  Google Scholar 

  • Takayama, K., Olsen, M., Datta, P., and Hunter, R. L., 1991, Adjuvant activity of non-ionic block copolymers. V. Modulation of antibody isotype by lipopolysaccharides, lipid A, and precursors, Vaccine 9:257–265.

    Article  PubMed  CAS  Google Scholar 

  • Thoelen, S., Van Damme, P., Meeus, A., Collard, F., Slaoui, M., and Vandepapeliere, P., 1993, Immunogenicity of a recombinant hepatitis B vaccine with monophosphoryl lipid A administered following various two-dose schedules, Abstr. 340, 33rd Intersci. Conf. Antimicrob. Agents Chemother., p. 182.

    Google Scholar 

  • Townsend, A., and Bodmer, H., 1989, Antigen recognition by class I-restricted T lymphocytes, Annu. Rev. Immunol. 7:601–624.

    Article  PubMed  CAS  Google Scholar 

  • Ulrich, J. T., Masihi, K. N., and Lange, W., 1988, Mechanisms of nonspecific resistance to microbial infections induced by trehalose dimycolate (TDM) and monophosphoryl lipid A (MPL), Adv. Biosci. 68:167–178.

    Google Scholar 

  • Van Damme, P., Thoelen, S., Van Passchen, M., Leroux-Roels, G., Meeus, A., Slaoui, M., and Vandepapeliere, P., 1993, Safety, humoral and cellular immunity of a recombinant hepatitis B vaccine with monophosphoryl lipid A in healthy volunteers, Abstr. 667, 33rd Intersci. Conf. Antimicrob. Agents Chemother., p. 241.

    Google Scholar 

  • Verghese, A., and Berk, S. L., 1983, Bacterial pneumonia in the elderly, Medicine (Baltimore) 62:271–285.

    CAS  Google Scholar 

  • Wherry, J. C., Schreiber, R. D., and Unanue, E. R., 1991, Regulation of gamma interferon production by natural killer cells in SCID mice: Roles of tumor necrosis factor and bacterial stimuli, Infect. Immun. 59:1709–1715.

    PubMed  CAS  Google Scholar 

  • Zhou, F., and Huang, L., 1993, Monophosphoryl lipid A enhances specific CTL induction by a soluble protein antigen entrapped in liposomes, Vaccine 11:1139–1144.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ribi ImmunoChem Research, Inc., Hamilton, Montana, 59840, USA

    J. Terry Ulrich & Kent R. Myers

Authors
  1. J. Terry Ulrich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kent R. Myers
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Genentech, Inc., South San Francisco, California, USA

    Michael F. Powell

  2. Vaxcel, Inc., Norcross, Georgia, USA

    Mark J. Newman

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media New York

About this chapter

Cite this chapter

Ulrich, J.T., Myers, K.R. (1995). Monophosphoryl Lipid A as an Adjuvant. In: Powell, M.F., Newman, M.J. (eds) Vaccine Design. Pharmaceutical Biotechnology, vol 6. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1823-5_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-1823-5_21

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5737-7

  • Online ISBN: 978-1-4615-1823-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation